ImageneBio (IMA) Cash from Investing Activities (2020 - 2025)

ImageneBio has disclosed Cash from Investing Activities across 6 years of filings, most recently posting -$37.3 million for Q3 2025.

• Cash from Investing Activities for Q3 2025 came in at -$37.3 million, down 166.85% year-over-year; the trailing twelve-month figure through Sep 2025 was -$50.4 million (down 260.44% YoY), and the FY2024 annual result was -$34.9 million, down 154.41% from the prior year.
• Cash from Investing Activities came in at -$37.3 million for Q3 2025 at ImageneBio, down from $32.9 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $55.8 million in Q3 2024 to a low of -$166.1 million in Q1 2022.
• The 5-year median for Cash from Investing Activities is $1.9 million (2021), against an average of -$4.2 million.
• Peak annual rise in Cash from Investing Activities reached 19546.74% in 2022, while the deepest fall reached 19691.54% in 2022.
• ImageneBio's Cash from Investing Activities stood at -$550000.0 in 2021, then jumped by 2008.91% to $10.5 million in 2022, then surged by 94.08% to $20.4 million in 2023, then slumped by 325.38% to -$45.9 million in 2024, then gained by 18.71% to -$37.3 million in 2025.
• The last three Cash from Investing Activities figures came in at -$37.3 million (Q3 2025), $32.9 million (Q2 2025), and -$45.9 million (Q4 2024), per Business Quant data.